Insulin Resistance, Renal Injury, Renal 1-α Hydroxylase, and Bone Homeostasis in Aged Obese Rats

Archives of Medical Research

Volumn 39, Issue 4, 2008, Pages 380-387

  Chang Quan, Huang ^a   Bi Rong, Dong ^a   Ping, He ^a   Zhen Chan, Lu ^a   Xiao Dong, Peng ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Aged; Bone mineral density; Insulin resistance; Obesity; Renal 1 hydroxylase

Indexed keywords

CALCITRIOL; GLUCOSE; OXYGENASE; VITAMIN D;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CONTROLLED STUDY; FEMUR; HOMEOSTASIS; INSULIN RESISTANCE; KIDNEY INJURY; LUMBAR VERTEBRA; MALE; NONHUMAN; OBESITY; RAT; URINE LEVEL; VITAMIN BLOOD LEVEL; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; BONE DENSITY; CALCITRIOL; DISEASE MODELS, ANIMAL; HOMEOSTASIS; HYDROXYCHOLECALCIFEROLS; INSULIN RESISTANCE; OBESITY; RATS; RATS, WISTAR; STEROID HYDROXYLASES; VITAMIN D;

EID: 41049104849     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2007.12.008     Document Type: Article

References (41)

1. Rosenbaum M., and Leibel R.L. Hirsch. Obesity. N Engl J Med 337 (1998) 396-407
2. Bray G.A. Health hazards of obesity. Endocrinol Metab Clinics North Am 25 (1996) 907-919
3. Smith S.R. The endocrinology of obesity. Endocrinol Metab Clinics North Am 25 (1996) 921-942
4. Parvanova A.I., Trevisan R., Iliev I.P., Dimitrov B.D., Vedovato M., Tiengo A., et al. Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion. Diabetes 55 (2006) 1456-1462
5. Hoehner C.M., Greenlund K.J., Rith-Najarian S., Casper M.L., and McClellan W.M. Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter-Tribal Heart Project. J Am Soc Nephrol 13 (2002) 1626-1634
6. Chan J.C., Tomlinson B., Nicholls M.G., Swaminathan R., Cheung C.K., Woo J., et al. Albuminuria, insulin resistance and dyslipidaemia in Chinese patients with non-insulin-dependent diabetes (NIDDM). Diabet Med 13 (1996) 150-155
7. Whaley-Connell A., Pavey B.S., Afroze A., and Bakris G.L. Obesity and insulin resistance as risk factors for chronic kidney disease. J Cardiometab Syndr 1 (2006) 209-214
8. Jong P.E., Verhave J.C., Pinto-Sietsma S.J., Hillege H.L., and PREVEND study group. Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord 26 suppl 4 (2002) S21-S14
9. Hall J.E., Henegar J.R., Dwyer T.M., Liu J., Da Silva A.A., Kuo J.J., et al. Is obesity a major cause of chronic kidney disease?. Adv Ren Replace Ther 11 (2004) 41-54
10. Abrass C.K. Overview: obesity: what does it have to do with kidney disease?. J Am Soc Nephrol 15 (2004) 2768-2772
11. Kramer H. Obesity and chronic kidney disease. Contrib Nephrol 151 (2006) 1-18
12. Fujikawa R., Okubo M., Egusa G., and Kohno N. Insulin resistance precedes the appearance of albuminuria in non-diabetic subjects: 6 years follow up study. Diab Res Clin Pract 53 (2001) 99-106 150-155
13. Wolf G. Cell cycle regulation in diabetic nephropathy. Kidney Int Suppl 77 (2000) 59-66
14. Yaqoob M., McClelland P., Patrick A.W., Stevenson A., Mason H., and Bell G.M. Tubulopathy with macroalbuminuria due to diabetic nephropathy and primary glomerulonephritis. Kidney Int Suppl 47 (1994) 101-104
15. Lane P.H., Steffes M.W., Fioretto P., and Mauer S.M. Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int 43 (1993) 661-667
16. Ziyadeh F.N. Significance of tubulointerstitial changes in diabetic renal disease. Kidney Int Suppl 54 (1996) 10-13
17. Ueno M., Kawashima S., Nishi S., Shimada H., Karasawa R., Suzuki Y., Maruyama Y., and Arakawa. Tubulointerstitial lesions in non-insulin dependent diabetes mellitus. Kidney Int Suppl 63 (1997) S191-S194
18. Cooper M.E., Gilbert R.E., and Jerums G. Diabetic vascular complications. Clin Exp Pharmacol Physiol 24 (1997) 770-775
19. Yaqoob M., McClelland P., Patrick A.W., Stevenson A., Mason H., White M.C., et al. Evidence of oxidant injury and tubular damage in early diabetic nephropathy. QJM 87 (1994) 601-607
20. Hsu C.H., and Patel S. Uremic plasma contains factors inhibiting 1 alpha-hydroxylase activity. J Am Soc Nephrol 3 (1992) 947-952
21. Lobaugh B., Boass A., Garner S.C., and Toverud S.U. Intensity of lactation modulates renal 1 alpha-hydroxylase and serum 1,25(OH)2D in rats. Am J Physiol 262 6 Pt 1 (1992) E840-E844
22. Boucher B.J. Hypovitaminosis D and risk of type 2 diabetes in British South Asians. Diab Med 23 (2006) 336
23. Mathieu C., Gysemans C., Giulietti A., and Bouillon R. Vitamin D and diabetes. Diabetologia 48 (2005) 1247-1257
24. Hitman N., Mannan M.F., McDermatt, Aganna E., Ogunkolade B.W., Hales C.N., et al. Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes 47 (1998) 688-690
25. Kadowski S., and Norman A. Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J Clin Invest 73 (1984) 759-766
26. Pietschmann P., Schernthaner G., and Woloszczuk W. Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications. Diabetologia 31 (1988) 892-895
27. Takeyama K., Kitanaka S., Sato T., Kobori M., Yanagisawa J., and Kato S. 25-Hydroxyvitamin D3 1α-hydroxylase and vitamin D synthesis. Science 277 (1997) 1827-1830
28. Ishimura E., Tsuchida T., Hirowatari K., Naka H., Imanishi Y., Miki T., et al. Annual change in bone mineral density in predialysis patients with chronic renal failure: significance of a decrease in serum 1,25-dihydroxy-vitamin D. J Bone Miner Metab 25 (2007) 74-79
29. Karkkainen M., Tahtela R., Laitinen K., Makela P., Lamberg-Allardt C., and Valimaki M.J. Bone mass and markers of bone and calcium metabolism in postmenopausal women treated with 1,25-dihydroxyvitamin D (Calcitriol) for four years. Calcif Tissue Int 67 (2000) 122-127
30. Blaedel W.J., and Uhl J.M. Nature of materials in serum that interfere in the glucose oxidase-peroxidase-O-dianisidine method for glucose, and their mode of action. Clin Chem 21 (1975) 119-124
31. Straczkowski M., Stepień A., Kowalska I., and Kinalska I. Comparison of simple indices of insulin sensitivity using the euglycemic hyperinsulinemic clamp technique. Int Med J Exp Clin Res 10 (2004) CR480-CR484
32. Watts G.F., Albano J.D., Bennett J.E., Morris R.W., Shaw K.M., and Polak A. Assessment of new radioimmunoassay kit for determining urinary albumin at low concentrations: comparison with radial immunodiffusion. J Clin Pathol 39 (1986) 1151-1154
33. Lilley J., Walters B.G., Heath D.A., and Drolc Z. In vivo and in vitro precision for bone density measured by dual-energy X-ray absorption. Osteopor Int 1 (1991) 141-146
34. Broholm B., Podenphant J., and Biering-Sorensen F. The course of bone mineral density and biochemical markers of bone turnover in early postmenopausal spinal cord-lesioned females. Spinal Cord 43 (2005) 674-677
35. Ahloulay M., Dechaux M., Laborde K., and Bankir L. Influence of glucagon on GFR and on urea and electrolyte excretion: direct and indirect effects. Am J Physiol 269 (1995) F225-F235
36. Nestler J.E., Barlascini C.O., and Tetrault G.A. Increased transcapillary escape rate of albumin in on-diabetic men in response to hyperinsulinemia. Diabetes 39 (1990) 1212-1217
37. Pinto-Sietsma S.J., Navis G., Janssen W.M., Zeeuw D., and Gans R.O. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 41 (2003) 733-741
38. Deckert T., Feldt-Rasmussen B., Djurup R., and Deckert M. Glomerular size and charge selectivity in insulin-dependent diabetes mellitus. Kidney Int 33 (1988) 100-106
39. Ziyadeh F.N., and Goldfarb S. The renal tubulointerstitium in diabetes mellitus. Kidney Int 39 (1991) 464-475
40. 2+ transport proteins in 25-hydroxyvitamin D3-1α-hydroxylase knockout mice. Kidney Int 66 (2004) 1082-1089
41. Armbrecht H.J., Boltz M.A., Ritter C.S., and Brown A.J. Parathyroid hormone stimulation of the renal 25-hydroxyvitamin D-1α-hydroxylase-effect of age and free radicals. J Steroid Biochem Mol Biol 103 (2007) 330-333